The United States has confirmed that it does not plan to impose travel restrictions on individuals arriving from African countries despite the rising cases of Mpox. Ambassador John Nkengasong clarified that such claims are unfounded and the U.S. will not reintroduce travel policies similar to those used during the COVID-19 pandemic.
Nkengasong emphasized that the U.S. will continue to work with the African Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO) to manage the Mpox outbreak. The U.S. has also committed an additional $35 million to support Mpox control efforts.
The WHO has declared Mpox a public health emergency of international concern twice, and the outbreak has significantly impacted countries in Africa, with the Democratic Republic of Congo being the most affected. The U.S. has already allocated over $2.65 billion in health funding to Central and East African countries and has provided more than $20 million to support Mpox response efforts.
